GlaxoSmithKline PLC — Director's Dealing 2013

Mar 4, 2013

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2022Z

GlaxoSmithKline PLC

04 March 2013

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

Vesting of conditional share awards under the

GlaxoSmithKline Share Value Plan

This notification sets out the vesting of awards over Ordinary Shares and American Depositary Shares (ADS) in GlaxoSmithKline plc, made in 2010 under the GlaxoSmithKline Share Value Plan (SVP), which were conditional on continued employment with the GlaxoSmithKline group.

The three-year vesting period for the 2010 SVP awards, which commenced on 23 February 2010, has now ended. The awards made to the connected persons of a Director and of a Person Discharging Managerial Responsibility (PDMR) vested on 1 March 2013 and details are given in the table below.

Name of Director / PDMR	Name of Connected person	Number of ADS vested	Number of Ordinary Shares vested
Mr P Thomson	Mrs K Thomson		837
Dr M Slaoui*	Mrs K Slaoui	640

* Denotes an Executive Director

The Company and the above individuals were advised of these transactions on 1 March 2013.

The fair market values of an Ordinary Share and of an ADS of GlaxoSmithKline plc at the point of vesting on 1 March 2013 were £14.55 and US$44.03 respectively.

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).

V A Whyte

Company Secretary

4 March 2013

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSVZLFBXXFLBBE